Literature DB >> 25255303

Preliminary dosimetric evaluation of (166)Ho-TTHMP for human based on biodistribution data in rats.

Hassan Yousefnia1, Samaneh Zolghadri2, Amir Reza Jalilian1, Mojtaba Tajik3, Mohammad Ghannadi-Maragheh1.   

Abstract

In this work, the absorbed dose to each organ of human for (166)Ho-TTHMP was evaluated based on biodistribution studies in rats by a RADAR method and was compared with (166)Ho-DOTMP as the only clinically used Ho-166 bone marrow ablative agent. The highest absorbed dose for this complex is observed in red marrow with 0.922mGy/MBq. The results show that (166)Ho-TTHMP has considerable characteristics compared to (166)Ho-DOTMP and can be a good candidate for bone marrow ablation in patients with multiple myeloma.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  (166)Ho-TTHMP; Bone marrow ablation; Internal dosimetry; RADAR

Mesh:

Substances:

Year:  2014        PMID: 25255303     DOI: 10.1016/j.apradiso.2014.08.017

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  6 in total

Review 1.  Cutting edge rare earth radiometals: prospects for cancer theranostics.

Authors:  Alexander W E Sadler; Leena Hogan; Benjamin Fraser; Louis M Rendina
Journal:  EJNMMI Radiopharm Chem       Date:  2022-08-26

2.  Estimation of human absorbed dose for (166)Ho-PAM: comparison with (166)Ho-DOTMP and (166)Ho-TTHMP.

Authors:  Mahdokht Vaez-Tehrani; Samaneh Zolghadri; Hassan Yousefnia; Hossein Afarideh
Journal:  Br J Radiol       Date:  2016-08-15       Impact factor: 3.039

3.  Absorbed dose assessment of (177)Lu-zoledronate and (177)Lu-EDTMP for human based on biodistribution data in rats.

Authors:  Hassan Yousefnia; Samaneh Zolghadri; Amir Reza Jalilian
Journal:  J Med Phys       Date:  2015 Apr-Jun

4.  Preclinical Study of 68Ga-DOTATOC: Biodistribution Assessment in Syrian Rats and Evaluation of Absorbed Dose in Human Organs.

Authors:  Mojdeh Naderi; Samaneh Zolghadri; Hassan Yousefnia; Ali Ramazani; Amir Reza Jalilian
Journal:  Asia Ocean J Nucl Med Biol       Date:  2016

5.  Human Absorbed Dose Estimation of 111In-DOTA-PR81 as a Novel High Potential Agent for Breast Cancer Imaging.

Authors:  Hassan Yousefnia; Samaneh Zolghadri; Behrouz Alirezapour
Journal:  J Med Phys       Date:  2022-08-05

Review 6.  The various therapeutic applications of the medical isotope holmium-166: a narrative review.

Authors:  Nienke J M Klaassen; Mark J Arntz; Alexandra Gil Arranja; Joey Roosen; J Frank W Nijsen
Journal:  EJNMMI Radiopharm Chem       Date:  2019-08-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.